Circulating adipocyte fatty acid-binding protein is a predictor of cardiovascular events in patients with stable angina undergoing percutaneous coronary intervention.
Wataru TakagiToru MiyoshiMasayuki DoiKeisuke OkawaKazumasa NosakaTomoyuki NishibeNaoaki MatsuoSatoshi HirohataHiroshi ItoPublished in: BMC cardiovascular disorders (2017)
UMIN Clinical Trials Registry UMIN000029283 (registration date: September 25, 2017), retrospectively registered.
Keyphrases
- cardiovascular events
- fatty acid
- coronary artery disease
- percutaneous coronary intervention
- binding protein
- clinical trial
- st segment elevation myocardial infarction
- coronary artery bypass grafting
- st elevation myocardial infarction
- acute myocardial infarction
- antiplatelet therapy
- acute coronary syndrome
- phase ii
- adipose tissue
- coronary artery bypass
- open label
- phase iii
- randomized controlled trial
- atrial fibrillation
- insulin resistance
- type diabetes
- study protocol
- heart failure
- metabolic syndrome
- coronary artery